Literature DB >> 31925340

Effect of rivaroxaban on urinary albumin excretion in patients with atrial fibrillation and chronic kidney disease: a randomized trial (X-NOAC).

Atsushi Tanaka1, Makoto Suzuki2, Kazuo Matsunaga3, Isao Taguchi4, Shiro Nakahara4, Atsuko Chihara5, Jun-Ichi Oyama5, Koichi Node6.   

Abstract

Entities:  

Year:  2020        PMID： 31925340     DOI： 10.1038/s41440-019-0384-6

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  1 in total

Review 1.  Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.

Authors:  Miho Kimachi; Toshi A Furukawa; Kimihiko Kimachi; Yoshihito Goto; Shingo Fukuma; Shunichi Fukuhara
Journal:  Cochrane Database Syst Rev       Date:  2017-11-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.